Concepedia

Yanru Qin

YQ

Statistics

Publications

68

Citations

5.9K

H-Index

35

Active since

2006

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

University of Hong Kong

Sun Yat-sen University

Sun Yat-sen University Cancer Center

Chinese University of Hong Kong

Yanru Qin is an author at First Affiliated Hospital of Zhengzhou University specializing in medicine, oncology, and esophageal cancer.

ORCID

Publications per year

2006–2025

68

Publications

68

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

Zhenggang Ren, Jianming Xu, Yuxian Bai et al. · The Lancet Oncology · 2021 · 1.1K citations

, , +13

Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results

Changsong Qi, Jifang Gong, Jian Li et al. · Nature Medicine · 2022 · 571 citations · Full text

, , +17

Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer

Jianming Xu, Haiping Jiang, Yueyin Pan et al. · JAMA · 2023 · 357 citations · Full text

, , +17

MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor

Kar Lok Kong, Dora L.�W. Kwong, Tim Hon-Man Chan et al. · Gut · 2011 · 238 citations

, , +17

Adenosine-to-Inosine RNA Editing Mediated by ADARs in Esophageal Squamous Cell Carcinoma

Yanru Qin, Jun-Jing Qiao, Tim Hon Man Chan et al. · Cancer Research · 2013 · 202 citations · Full text

, , +17

1–5 of 68